Home  >  Products  >  Nme1 (non-metastatic cells 1, protein (NM23A) expressed in ) Blocking Peptide (the C terminal of Nme1)(100ug)
Nme1 (non-metastatic cells 1, protein (NM23A) expressed in ) Blocking Peptide (the C terminal of Nme1)(100ug)

Nme1 (non-metastatic cells 1, protein (NM23A) expressed in ) Blocking Peptide (the C terminal of Nme1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-Nme1 Antibody (ARP38169_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human, Mouse
Presku: AAP38169
Size: 100ug
Weight: 17kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: Nme1 has a major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate. It possesses nucleoside-diphosphate kinase, serine/threonine-specific protein kinase, geranyl and farnesyl pyrophosphate kinase, histidine protein kinase and 3'-5' exonuclease activities. It is involved in cell proliferation, differentiation and development, signal transduction, G protein-coupled receptor endocytosis, and gene expression. Itis required for neural development including neural patterning and cell fate determination.
Alternative names: AL024257; NDPK-A; NM23-M1; NM23A
See Full Product Listings >